NeoCodex is a human genetics-based biotechnology company specialized in providing biomaterials, analysis, and project development services.
NeoCodex is providing a deeper understanding of the genetic roots of disease. Applying NeoCodex's breakthrough whole genome association study (WGAS) technology, genomic services and biomaterials, researchers are gaining a clearer path to creating tomorrow's medicines through uncovering a greater understanding of human genetics and genetic variability.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 29, 2006 | Series Unknown | €645K | 1 | Invercaria | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Invercaria | Yes | Series Unknown |